← All candidates
Two insiders bought $4.87M in six days.
10 filings on record.
HELPCYBIN INC.
NasdaqGM · Healthcare · $979.97M
$13.47
+2.67% today
Two insiders bought $4.87M in six days.
Led by Glavine Paul, chief growth officer.
Price · 1Y · daily● 6 buys
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what HELP ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$979.97M
Float
58.7M
80% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Growth Officer
Glavine Paul
Bought $1.25M on Sep 8 — 100,000 sh @ $12.47, held direct, 2.3% of their stake.
No completed positions to measure
Executive Chair
So Eric H. L.
Bought $1.24M on Sep 8 — 100,000 sh @ $12.39, held direct, 2.2% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
3 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
1 more transaction on Pro →Context
Wall St
$41.56 avg target
+208.5% vs today · 9 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q2 '26−$1.26 act+$0.12
Q1 '26−$1.21 act−$0.07
Q4 '25−$1.36 act−$0.39
Q3 '25−$1.65 act−$0.33
Coverage
Cybin (HELP) Gets A Fresh Look On Trial Progress And CEO ChangeSimply Wall St. · 3w agoCybin (CYBN) Stock Sees Fair Value Lift As Sector Research Supports Growth AssumptionsSimply Wall St. · 3w agoCybin Conference: Helus CEO Eyes Q4 Phase III Depression Data for HLP003MarketBeat · 08-14Cybin (HELP) Names New CEO, Is The Stock Still Cheap?Simply Wall St. · 08-08
The file stays open
10 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice